Skip to content
Review Open access

Precision Cardio-Oncology: A Multimodal Approach to Cancer Therapy-Related Cardiovascular Toxicity Prediction and Assessment

Oct 2026 · Cancers · Vol 18 · 0 citations · 129 references
Medicine

Abstract

Simple Summary Cancer treatments can cause cardiovascular toxicity, and research shows cancer survivors have an increased risk of cardiovascular disease. However, risk varies from person to person, so research efforts have focused on developing new methods to predict cancer therapy-related cardiovascular toxicity (CTR-CVT) to inform cancer treatment planning and guide initiation of cardioprotective treatment. The growth of novel scientific fields, such as multi-omics (the comprehensive assessment of multiple biological molecules) and radiomics (the assessment of quantitative features, such as pixel intensity, embedded in medical images), offers a potential way to individualise CTR-CVT prediction and assessment further, enabling more robust cancer treatment decisions. In this review, we consider the evidence supporting a multimodal approach to CTR-CVT assessment and prediction.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.